INHA and cancer: Furthermore, in parallel experiments, ImmTAB-inhA molecules did not induce IFN-γ secretion by PBMC in response to a panel of inhA antigen negative cancer cell lines expressing various levels of HLA-E and presenting different sets of endogenous HLA-E ligands.